Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
Sylvie Perreault, Robert Côté, Brian White-Guay, Marc Dorais, Essaïd Oussaïd, Mireille E. Schnitzer
J Stroke. 2019;21(2):195-206.   Published online 2019 May 31     DOI: https://doi.org/10.5853/jos.2018.02243
Citations to this article as recorded by Crossref logo
Anticoagulation after intracerebral hemorrhage in patients with atrial fibrillation: between Scylla and Charybdis
Carla Seabra Abrantes, Mariana Pintalhão, Sofia Tavares, Luísa Fonseca, Paulo Castro Chaves
Neurological Sciences.2022; 43(4): 2441.     CrossRef
Stroke prevention strategies in high-risk patients with atrial fibrillation
Agnieszka Kotalczyk, Michał Mazurek, Zbigniew Kalarus, Tatjana S. Potpara, Gregory Y. H. Lip
Nature Reviews Cardiology.2021; 18(4): 276.     CrossRef
Antithrombotic therapy for stroke prevention in patients with atrial fibrillation who survive an intracerebral haemorrhage: results of an EHRA survey
Elena Ivany, Deirdre A Lane, Gheorghe-Andrei Dan, Wolfram Doehner, Michal M Farkowski, Konstantinos Iliodromitis, Radoslaw Lenarczyk, Tatjana S Potpara
EP Europace.2021; 23(5): 806.     CrossRef
Anticoagulation in Acute Neurological Disease
Cina Sasannejad, Kevin N. Sheth
Seminars in Neurology.2021; 41(05): 530.     CrossRef
Oral anticoagulant therapy in patients after intracerebral hemorrhage
A. A. Kulesh, L. I. Syromyatnikova
Neurology, Neuropsychiatry, Psychosomatics.2020; 12(3): 4.     CrossRef
Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy
José Miguel Rivera-Caravaca, María Asunción Esteve-Pastor, Anny Camelo-Castillo, Inmaculada Ramírez-Macías, Gregory Y. H. Lip, Vanessa Roldán, Francisco Marín
Expert Opinion on Pharmacotherapy.2020; 21(15): 1867.     CrossRef